Skip to main content
. 2021 Mar 11;10(3):432. doi: 10.3390/antiox10030432

Table 1.

Baseline general characteristics and training variables of the cyclists.

2S-Hesperidin Placebo p-Value
Age (years) 35.0 (9.20) 32.6 (8.90) 0.407
Body mass (kg) 71.0 (6.98) 70.4 (6.06) 0.773
Height (cm) 175.3 (6.20) 176.5 (6.10) 0.541
BMI (kg·m−2) 23.1 (1.53) 22.6 (1.43) 0.292
BF (%) 8.9 (1.63) 9.0 (1.64) 0.803
VO2MAX (L·min−1) 3.99 (0.36) 3.98 (0.63) 0.971
VO2MAX (mL·kg−1·min−1) 57.5 (6.97) 57.9 (9.53) 0.88
HRMAX (bpm) 184.9 (11.11) 183.2 (8.68) 0.593
VT1 (%) 50.9 (5.63) 50.0 (4.78) 0.61
VT2 (%) 84.9 (5.85) 84.1 (5.70) 0.644
Training variables 2S-Hesperidin Placebo p-value
Total distance (km) 1121.12 (534.99) 1082.43 (810.46) 0.868
HRAVG (bpm) 144.76 (8.88) 137.48 (13.11) 0.067
WAVG (W) 174.86 (15.79) 163.47 (32.49) 0.435
RPE 6.34 (0.82) 6.33 (1.16) 0.975

Values are expressed as mean (SD). BMI = body mass index; BF = body fat; VO2max = maximum oxygen volume; VT1 = ventilatory threshold 1 (aerobic); VT2 = ventilatory threshold 2 (anaerobic); Total distance = of all the training sessions carried out during the study period; HRavg = average heart rate of all the training sessions carried out during the study period; Wavg = average power output of all training sessions during the study period and RPE = rating of perceived exertion of all training sessions during the study.